Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine: Lyon, France Saturday, July 12, 2025, 18:00 Hrs [IST] Osivax ...

Onco-Innovations appoints Dr. Islam Mohamed as advisory board chair to accelerate development of innovative oncology solutions: Vancouver, BC Saturday, July 12, 2025, 14:30 Hrs [I ...

Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...

UKHSA data shows 85% of parents are confident childhood vaccines are safe, effective and trustworthy: United Kingdom Saturday, July 12, 2025, 14:00 Hrs [IST] New data published by ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...

Intelligent Bio Solutions to present pharmacokinetic study data at ADLM 2025 Clinical Lab Expo: New York Saturday, July 12, 2025, 13:00 Hrs [IST] Intelligent Bio Solutions Inc, a ...

US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...

Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...

Ichnos Glenmark Innovation & AbbVie ink exclusive global licensing agreement for ISB 2001: New York Saturday, July 12, 2025, 12:00 Hrs [IST] IGI Therapeutics SA, a wholly owned su ...

Nandita Vijayasimha, Bengaluru Saturday, July 12, 2025, 08:00 Hrs [IST] ...

Pharmexcil urges member exporters to respond to Mauritius medicine requirement: Shardul Nautiyal, Mumbai Saturday, July 12, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promot ...